247 related articles for article (PubMed ID: 7757293)
21. Utility of DNA flow cytometry in distinguishing between malignant and benign intrahepatic biliary lesions.
Wen KW; Rabinovitch PS; Wang D; Mattis AN; Ferrell LD; Choi WT
Virchows Arch; 2020 Oct; 477(4):527-534. PubMed ID: 32296928
[TBL] [Abstract][Full Text] [Related]
22. Cholangiocarcinoma occurring in a liver with multiple bile duct hamartomas (von Meyenburg complexes).
Röcken C; Pross M; Brucks U; Ridwelski K; Roessner A
Arch Pathol Lab Med; 2000 Nov; 124(11):1704-6. PubMed ID: 11079031
[TBL] [Abstract][Full Text] [Related]
23. Diffuse hyperplasia of the peribiliary glands.
Dumas A; Thung SN; Lin CS
Arch Pathol Lab Med; 1998 Jan; 122(1):87-9. PubMed ID: 9448024
[TBL] [Abstract][Full Text] [Related]
24. Immunostaining for polycomb group protein EZH2 and senescent marker p16INK4a may be useful to differentiate cholangiolocellular carcinoma from ductular reaction and bile duct adenoma.
Sasaki M; Matsubara T; Kakuda Y; Sato Y; Nakanuma Y
Am J Surg Pathol; 2014 Mar; 38(3):364-9. PubMed ID: 24487593
[TBL] [Abstract][Full Text] [Related]
25. [A case report of cholangiectasis with cholangiocarcinoma].
Nagata T; Ikoma H; Komiyama S; Nishio M; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Ochiai T; Sakakura C; Kokuba Y; Sonoyama T; Otsuji E
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2429-32. PubMed ID: 22202403
[TBL] [Abstract][Full Text] [Related]
26. Pathological aspects of cholangiocarcinoma.
Weinbren K; Mutum SS
J Pathol; 1983 Feb; 139(2):217-38. PubMed ID: 6298394
[TBL] [Abstract][Full Text] [Related]
27. Atypical bile duct adenoma, clear cell type: a previously undescribed tumor of the liver.
Albores-Saavedra J; Hoang MP; Murakata LA; Sinkre P; Yaziji H
Am J Surg Pathol; 2001 Jul; 25(7):956-60. PubMed ID: 11420469
[TBL] [Abstract][Full Text] [Related]
28. Bile duct adenoma: imaging features and radiologic-pathologic correlation.
Tatsumi R; Ichihara S; Suii H; Yamaguchi M; Arakawa T; Nakajima T; Kuwata Y; Ozeki I; Hige S; Toyota J; Karino Y
Jpn J Radiol; 2020 Jun; 38(6):561-571. PubMed ID: 32128668
[TBL] [Abstract][Full Text] [Related]
29. A subgroup of intrahepatic cholangiocarcinoma with an infiltrating replacement growth pattern and a resemblance to reactive proliferating bile ductules: 'bile ductular carcinoma'.
Kozaka K; Sasaki M; Fujii T; Harada K; Zen Y; Sato Y; Sawada S; Minato H; Matsui O; Nakanuma Y
Histopathology; 2007 Sep; 51(3):390-400. PubMed ID: 17553067
[TBL] [Abstract][Full Text] [Related]
30. Intraductal variant of peripheral cholangiocarcinoma of the liver with Clonorchis sinensis infection.
Kim YI; Yu ES; Kim ST
Cancer; 1989 Apr; 63(8):1562-6. PubMed ID: 2538218
[TBL] [Abstract][Full Text] [Related]
31. BRAF V600E mutation in biliary proliferations associated with α
Angkathunyakul N; Rosini F; Heaton N; Foskett P; Quaglia A
Histopathology; 2017 Feb; 70(3):485-491. PubMed ID: 27627051
[TBL] [Abstract][Full Text] [Related]
32. Bile duct adenoma may be a precursor lesion of small duct type intrahepatic cholangiocarcinoma.
Sasaki M; Sato Y; Nakanuma Y
Histopathology; 2021 Jan; 78(2):310-320. PubMed ID: 33405289
[TBL] [Abstract][Full Text] [Related]
33. Biliary tumors of the liver.
Colombari R; Tsui WM
Semin Liver Dis; 1995 Nov; 15(4):402-13. PubMed ID: 8578323
[No Abstract] [Full Text] [Related]
34. Reply to Letter to the Editor by Pujals et al.
Aishima S; Tanaka Y; Kubo Y; Shirabe K; Maehara Y; Oda Y
Pathol Int; 2015 Jun; 65(6):339. PubMed ID: 25941096
[No Abstract] [Full Text] [Related]
35. Cholangiocarcinoma arising in congenital hepatic fibrosis. A case report.
Daroca PJ; Tuthill R; Reed RJ
Arch Pathol; 1975 Nov; 99(11):592-5. PubMed ID: 179515
[TBL] [Abstract][Full Text] [Related]
36. [Cholangiocarcinoma associated with Caroli's disease].
Yoshikawa K; Ito A; Nishimura M; Kishima H; Ichikawa H; Akagi H; Minami M; Han N; Tsujimura T
Gan No Rinsho; 1988 Jan; 34(1):73-80. PubMed ID: 2828714
[TBL] [Abstract][Full Text] [Related]
37. Cholangiocarcinoma coexisting with developmental liver cysts: a distinct entity different from liver cystadenocarcinoma.
Azizah N; Paradinas FJ
Histopathology; 1980 Jul; 4(4):391-400. PubMed ID: 6253379
[TBL] [Abstract][Full Text] [Related]
38. Pathology of hepatolithiasis: cholangitis and cholangiocarcinoma.
Ohta G; Nakanuma Y; Terada T
Prog Clin Biol Res; 1984; 152():91-113. PubMed ID: 6089228
[No Abstract] [Full Text] [Related]
39. Magnetic resonance findings of bile duct adenoma with calcification.
Maeda E; Uozumi K; Kato N; Akahane M; Inoh S; Inoue Y; Beck Y; Goto A; Makuuchi M; Ohtomo K
Radiat Med; 2006 Jul; 24(6):459-62. PubMed ID: 16958429
[TBL] [Abstract][Full Text] [Related]
40. Intrahepatic cholangiocarcinoma and portal hypertension developing in a patient with multicystic biliary microhamartomas.
Sugawara T; Shindoh J; Hoshi D; Hashimoto M
Malays J Pathol; 2018 Dec; 40(3):331-335. PubMed ID: 30580365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]